Central Precocious Puberty: Update on Diagnosis and Treatment.
Central Precocious Puberty: Update on Diagnosis and Treatment.
复制标题
DOI:
10.1007/s40272-015-0130-8
复制
发表时间:
2015-08
期刊:
影响因子:
--
通讯作者:
Eugster EA
中科院分区:
文献类型:
--
作者:
Chen M;Eugster EA
Central precocious puberty (CPP) is characterized by the same biochemical and physical features as normally timed puberty but occurs at an abnormally early age. Most cases of CPP are seen in girls, in whom it is usually idiopathic. In contrast, ∼50 % of boys with CPP have an identifiable cause. The diagnosis of CPP relies on clinical, biochemical, and radiographic features. Untreated, CPP has the potential to result in early epiphyseal fusion and a significant compromise in adult height. Thus, the main goal of therapy is preservation of height potential. The gold-standard treatment for CPP is go-nadotropin-releasing hormone (GnRH) analogs (GnRHa). Numerous preparations with a range of delivery systems and durations of action are commercially available. While the outcomes of patients treated for CPP have generally been favorable, more research about the psychological aspects, optimal monitoring, and long-term effects of all forms of GnRHa treatment is needed. Several potential therapeutic alternatives to GnRHa exist and await additional investigation.
登录
查看更多内容
影响因子:
5.8
作者:
de Vries, L;Kauschansky, A;Phillip, M
通讯作者:
Phillip, M
DOI:
10.1056/nejmoa1302160
发表时间:
2013-06-27
期刊:
The New England journal of medicine
影响因子:
--
作者:
Abreu AP;Dauber A;Macedo DB;Noel SD;Brito VN;Gill JC;Cukier P;Thompson IR;Navarro VM;Gagliardi PC;Rodrigues T;Kochi C;Longui CA;Beckers D;de Zegher F;Montenegro LR;Mendonca BB;Carroll RS;Hirschhorn JN;Latronico AC;Kaiser UB
通讯作者:
Kaiser UB
影响因子:
5.8
作者:
Macedo, Delanie B.;Abreu, Ana Paula;Latronico, Ana Claudia
通讯作者:
Latronico, Ana Claudia
影响因子:
5.8
作者:
Lee, Peter A.;Klein, Karen;Bacher, Peter
通讯作者:
Bacher, Peter
影响因子:
2.2
作者:
Choi, Keun Hee;Chung, Seung Joon;Yang, Sei Won
通讯作者:
Yang, Sei Won